For The Better

The copper miner’s stock took another hit today along with other economically aligned stocks.

The footwear maker is getting blasted by inflation worries.

Germany’s flirtation with legalizing recreational marijuana among adults is lighting a fire under the company’s shares today.

The networking infrastructure specialist reported mildly disappointing results in the second quarter of 2022. That’s not the whole story, though.

A surprising choice for an ad-tech partner caught the digital advertising industry by surprise.

The company’s underwhelming third-quarter earnings forecast is weighing on its shares.

The video game retailer is coming hot out of the gate and surprising its critics.

Healthcare has become a bona fide stock picker’s market this year.

JPMorgan Chase’s CEO sees conditions getting worse before they get better.

A few stock price target cuts by analysts and sky-high inflation are weighing down these tech leaders.

Issuing new shares will leave it with plenty of money in the bank.

The bank reported disappointing second-quarter results Thursday morning.

Another potential catalyst would be surging second-quarter profits.

Stock splits make headlines a lot, but it’s always important to consider fundamentals first when investing.

Don’t be so consumed by the current market-wide weakness that you look right past obvious growth stories.

Investors are giving heavier weight to Novavax’s bad news than to its good news.

The apparel retailer’s turnaround CEO just turned around and left.

The packaged foods giant is still a great defensive investment.

The decline in share price may not be all that surprising given Doximity’s egregious valuation last year.

Autopilot needs a new driver.